Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Coagulation disorders in cancer

K E Goad¹, H R Gralnick

¹Clinical Pathology Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.

Hematology/Oncology Clinics of North America

|April 1, 1996

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Conformational regulation of the fibronectin binding and alpha 3beta 1 integrin-mediated adhesive activities of thrombospondin-1.

The Journal of biological chemistry·2001

Same author

Hypergranular promyelocytic leukemia: correlation between morphology and chromosomal translocations including t(15;17) and t(11;17).

Leukemia·2000

Same author

Plasma glycocalicin in platelet concentrates: relationship to other parameters of the storage lesion.

Thrombosis research·1998

Same author

Glycocalicin levels in the plasma of HIV+ patients: an indicator of platelet turnover.

The Journal of laboratory and clinical medicine·1998

Same author

Platelet von Willebrand factor in Hermansky-Pudlak syndrome.

American journal of hematology·1998

Same author

Structure-function studies on the inhibition of binding of alpha-thrombin to platelet GpIb alpha by the peptide D-Y-Y-P-E and the artifactual inhibitory activity of C-terminal E in this peptide.

Thrombosis research·1998

Cancer patients frequently experience coagulation disorders, leading to bleeding or clotting. This review covers laboratory findings, clinical signs like Trousseau

Area of Science:

Hematology
Oncology

Background:

Coagulation disorders are a frequent complication in cancer patients.
Malignancy is associated with both bleeding and clotting risks.

Purpose of the Study:

To review coagulation laboratory findings in cancer patients.
To discuss thromboembolic and hemorrhagic manifestations of malignancy.
To cover specific coagulation syndromes and their management.

Main Methods:

Literature review of coagulation disorders in cancer.
Analysis of laboratory findings.
Discussion of clinical manifestations and treatment.

Main Results:

Cancer patients exhibit diverse coagulation abnormalities.

Related Experiment Videos

Thromboembolic events (e.g., Trousseau's syndrome) and bleeding complications are common.

Disseminated intravascular coagulation and acquired von Willebrand disease are key syndromes.

Conclusions:

Understanding coagulation laboratory findings is crucial for managing cancer-associated thrombosis and hemorrhage.
Timely diagnosis and treatment of coagulation disorders improve patient outcomes.